Search

Your search keyword '"Møller, Christian Holdflod"' showing total 9 results
Start Over Author "Møller, Christian Holdflod"
9 results on '"Møller, Christian Holdflod"'

1. GLP-1 increases heart rate by a direct action on the sinus node

Author

Lubberding, Anniek Frederike, primary, Veedfald, Simon, additional, Achter, Jonathan Samuel, additional, Nissen, Sarah Dalgas, additional, Soattin, Luca, additional, Sorrentino, Andrea, additional, Vega, Estefania Torres, additional, Linz, Benedikt, additional, Eggertsen, Caroline Harriet Eggert, additional, Mulvey, John, additional, Toräng, Signe, additional, Larsen, Sara Agnete, additional, Nissen, Anne, additional, Petersen, Lonnie Grove, additional, Bilir, Secil Erbil, additional, Bentzen, Bo Hjorth, additional, Rosenkilde, Mette Marie, additional, Hartmann, Bolette, additional, Lilleør, Thomas Nikolaj Bang, additional, Qazi, Saddiq, additional, Møller, Christian Holdflod, additional, Tfelt-Hansen, Jacob, additional, Sattler, Stefan Michael, additional, Jespersen, Thomas, additional, Holst, Jens Juul, additional, and Lundby, Alicia, additional

Published
2024
Full Text
View/download PDF

4. Efficacy of a glucagon-like peptide-1 agonist and restrictive versus liberal oxygen supply in patients undergoing coronary artery bypass grafting or aortic valve replacement: study protocol for a 2-by-2 factorial designed, randomised clinical trial

Author

Wiberg, Sebastian, primary, Kjaergaard, Jesper, additional, Møgelvang, Rasmus, additional, Møller, Christian Holdflod, additional, Kandler, Kristian, additional, Ravn, Hanne, additional, Hassager, Christian, additional, Køber, Lars, additional, and Nilsson, Jens Christian, additional

Published
2021
Full Text
View/download PDF

8. Single center outcomes after temporary mechanical circulatory assist device prior to Heartmate 3 implantation - a retrospective cohort study.

Author

Iversen IJ, Gustafsson F, Rossing K, Møller-Sørensen PH, Olsen PS, and Møller CH

Subjects
Humans, Retrospective Studies, Male, Female, Middle Aged, Time Factors, Treatment Outcome, Risk Factors, Adult, Aged, Prosthesis Implantation instrumentation, Prosthesis Implantation adverse effects, Prosthesis Implantation mortality, Risk Assessment, Prosthesis Design, Heart-Assist Devices, Hemodynamics, Shock, Cardiogenic physiopathology, Shock, Cardiogenic mortality, Shock, Cardiogenic therapy, Shock, Cardiogenic diagnosis, Ventricular Function, Left, Recovery of Function, Heart Failure physiopathology, Heart Failure therapy, Heart Failure mortality, Heart Failure diagnosis
Abstract

Objectives . Temporary mechanical circulatory support (TMCS) has become a component in the therapeutic strategy for treatment of cardiogenic shock as a bridge-to-decision. TMCS can facilitate recovery of cardiopulmonary function, end-organ function, and potentially reduce the surgical risk of left ventricular assist device (LVAD) implantation. Despite the improvements of hemodynamics and end-organ function, post-LVAD operative morbidity might be increased in these high-risk patients. The aim of the study was to compare outcomes after Heartmate 3 (HM3) implantation in patients with and without TMCS prior to HM3 implant. Methods. In this retrospective cohort study of all HM3 patients in the period between November 2015 and October 2021, patients with and without prior TMCS were compared. Patients' demographics, baseline clinical characteristics, laboratory tests, intraoperative variables, postoperative outcomes, and adverse events were collected from patient records. Results. The TMCS group showed an improvement in hemodynamics prior to LVAD implantation. Median TMCS duration was 19.5 (14-26) days. However, the TMCS group were more coagulopathic, had more wound infections, neurological complications, and more patients were on dialysis compared with patient without TMCS prior to HM3 implantation. Survival four years after HM3 implantation was 80 and 82% in the TMCS ( N  = 22) and non-TMCS group ( N  = 41), respectively. Conclusion . Patients on TMCS had an acceptable short and long-term survival and comparable to patients receiving HM3 without prior TMCS. However, they had a more complicated postoperative course.

Published
2024
Full Text
View/download PDF

9. [The first 25 years of lung transplantations in Denmark].

Author

Lund TK, Møller CH, Davidsen JR, Schultz HHL, Bredahl P, Ravn J, Olsen PS, Bendstrup E, and Perch M

Subjects
Denmark, History, 20th Century, History, 21st Century, Humans, Retrospective Studies, Lung Diseases, Interstitial, Lung Transplantation history, Pulmonary Disease, Chronic Obstructive
Abstract

Lung transplantation (LTx) has been performed in Denmark since 1992, and chronic obstructive pulmonary disease and interstitial lung diseases are the major indications. All candidates are subject to an intensive evaluation before being accepted for LTx. Follow-up after transplantation is life-long and includes immunosuppressive medication with a high risk of side effects. The median survival in Denmark is 7.0 years. Chronic rejection is common, diagnosed by declining lung function, and it is the most important factor for morbidity and mortality. LTx requires dedicated personnel in an interdisciplinary organisation.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results